Acne is a disfiguring disorder of the skin with significant cosmetic morbidity that may lead to serious psychological and social dysfunction. The skin disease comes in two forms. The most well-known form is Acne vulgaris (referred to as acne), which mostly manifests in teens but may continue into the early 20s. The second form is called Acne rosacea (referred to as rosacea) and mostly affects 30- to 60-year-olds. The two forms, despite sharing a common prefix, are quite unrelated in their respective pathophysiology, have different approaches to treatment and hence are considered two separate conditions. The conventional drug delivery system is efficient in the management of acne but poor patient compliance and adverse effects limit its efficacy. Lipid nanoparticles are novel nano lipid carriers made from biocompatible lipid which reduces toxicity; improve physical stability, skin hydration, and film formation. Furthermore, lipid nanoparticles protect the encapsulated drug from degradation. Thus current review focused on the potential use of lipid nanoparticles for the management of acne.

Tuberculosis (TB) remains a major global health problem as it is the second leading cause of death after the human immunodeficiency virus (HIV). Conventional chemotherapy fail either because of emergence of multidrug resistance or poor patient compliance to the drug regimen . The aim of this review is to give an update on advantages of solid lipid nanoparticles for tr Direct lung delivery of anti-TB drugs using pulmonary delivery systems is then reviewed since it appears as an interesting strategy to improve first and second line drugs. A particular focu inhalable dry powder formulations of antitubercular drugs to target alveolar macrophages where the bacteria develop. Numerous studies show that anti delivered as dry powders to the deep lungs for instantaneous, targeted and/or controlled release. These new formulations appear as interesting alternatives to deliver directly drugs to the lungs and favor efficient TB treatment.Tuberculosis (TB) remains a major global health problem as it is the second leading cause of death after the human immunodeficiency virus (HIV). Conventional chemotherapy fail either because of emergence of multidrug resistance or poor patient compliance to the drug regimen . The aim of this review is to give an update on advantages of solid lipid nanoparticles for treatment of tuberculosis and current antitubercular chemotherapies.TB drugs using pulmonary delivery systems is then reviewed since it appears as an interesting strategy to improve first and second line drugs. A particular focus is place on research performed on inhalable dry powder formulations of antitubercular drugs to target alveolar macrophages where the bacteria develop. Numerous studies show that anti-TB drugs can be incorporated into lipid nanoparticles which can be vered as dry powders to the deep lungs for instantaneous, targeted and/or controlled release. These new formulations appear as interesting alternatives to deliver directly drugs to the lungs and favor efficient TB treatment. Tuberculosis, Solid Lipid Nanoparticles, Oral and inhalable drug delivery, Targeted delivery to Vipul Sansare THE POTENTIAL ADVANTAGES OF SOLID LIPID NANOPARTICLES IN CHEMOTHERAPY OF vali, Maharashtra, India. Tuberculosis (TB) remains a major global health problem as it is the second leading cause of death after the human immunodeficiency virus (HIV). Conventional chemotherapy fail either because of emergence of multidrugresistance or poor patient compliance to the drug regimen . The aim of this review is to give an update on eatment of tuberculosis and current antitubercular chemotherapies.TB drugs using pulmonary delivery systems is then reviewed since it appears as an s is place on research performed on inhalable dry powder formulations of antitubercular drugs to target alveolar macrophages where the bacteria TB drugs can be incorporated into lipid nanoparticles which can be vered as dry powders to the deep lungs for instantaneous, targeted and/or controlled release. These new formulations appear as interesting alternatives to deliver dir...